About Us
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012.
| Publication Type | Conference Paper |
| Authors | O'Reilly M, Kohn D, Bartlett J, Benson J, Brooks P, Byrne B, Camozzi C, Cornetta K, Crystal R, Fong Y, Gargiulo L, Gopal-Srivastava R, High K, Jacobson S, Jambou R, Montgomery M, Rosenthal E, Samulski R, Skarlatos S, Sorrentino B, Wilson J, Xie Y, Corrigan-Curay J |
| Journal | Hum Gene Ther |
| Volume | 24 |
| Issue | 4 |
| Pagination | 355-62 |
| Date Published | 04/01/2013 |
| ISSN | 1557-7422 |
| Keywords | Rare Diseases |
| Abstract | Gene therapy has shown clinical efficacy for several rare diseases, using different approaches and vectors. The Gene Therapy for Rare Diseases workshop, sponsored by the National Institutes of Health (NIH) Office of Biotechnology Activities and Office of Rare Diseases Research, brought together investigators from different disciplines to discuss the challenges and opportunities for advancing the field including means for enhancing data sharing for preclinical and clinical studies, development and utilization of available NIH resources, and interactions with the U.S. Food and Drug Administration. |
| DOI | 10.1089/hum.2013.064 |
| PubMed ID | 23517518 |
| PubMed Central ID | PMC3631014 |